Comments on Waldeyeret al. ‘Response to Hexet al. Estimating the current and future costs for Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs’

2013 ◽  
Vol 30 (4) ◽  
pp. 503-504
Author(s):  
N. Hex ◽  
M. Taylor ◽  
C. Bartlett
2015 ◽  
Vol 32 (9) ◽  
pp. 1119-1120 ◽  
Author(s):  
N. Holman ◽  
B. Young ◽  
R. Gadsby

2022 ◽  
Vol 16 (1) ◽  
pp. 18-25
Author(s):  
Linda Nazarko

The coronavirus (COVID-19) pandemic has highlighted the importance of public health in the UK and globally. The UK's death rates and obesity rates are related and many people in the UK experience poor health because they are overweight or obese ( Lobstein, 2021 ; Mohammad et al, 2021 ). Obesity increases the risks of developing type 2 diabetes. People with both type 1 and type 2 diabetes are at greater risk of developing severe COVID symptoms, of requiring hospital treatment and of poor outcomes and death ( Barron et al, 2020 ). This article, the fifth in a series, examines risk factors for type 2 diabetes and explains how readers can reduce their risk of developing type 2 diabetes.


2013 ◽  
Vol 31 (3) ◽  
pp. 357-365 ◽  
Author(s):  
A. McGrogan ◽  
J. Snowball ◽  
C. S. de Vries
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document